These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12971147)

  • 1. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant.
    Bahamondes L; Hidalgo M; Petta CA; Diaz J; Espejo-Arce X; Monteiro-Dantas C
    J Reprod Med; 2003 Aug; 48(8):637-40. PubMed ID: 12971147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of enlarged ovarian follicles among users of levonorgestrel subdermal contraceptive implants (Norplant).
    Alvarez-Sanchez F; Brache V; de Oca VM; Cochon L; Faúndes A
    Am J Obstet Gynecol; 2000 Mar; 182(3):535-9. PubMed ID: 10739504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants.
    Hidalgo MM; Lisondo C; Juliato CT; Espejo-Arce X; Monteiro I; Bahamondes L
    Contraception; 2006 May; 73(5):532-6. PubMed ID: 16627041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing persistent ovarian follicles in premenopausal women fitted with the levonorgestrel-releasing intrauterine system.
    Morelli M; Di Cello A; Zullo F
    Int J Gynaecol Obstet; 2013 Feb; 120(2):187. PubMed ID: 23195289
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
    Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
    Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS).
    Selim MF; Hussein AF
    Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.
    Godfrey EM; Memmel LM; Neustadt A; Shah M; Nicosia A; Moorthie M; Gilliam M
    Contraception; 2010 Feb; 81(2):123-7. PubMed ID: 20103449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Norplant contraceptive on the bones of Nigerian women as assessed by quantitative ultrasound and serum markers of bone turnover.
    Vanderjagt DJ; Sagay AS; Imade GE; Farmer SE; Glew RH
    Contraception; 2005 Sep; 72(3):212-6. PubMed ID: 16102558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cytology associated with levonorgestrel contraception.
    Misra JS; Engineer AD; Tandon P
    Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
    Bahamondes MV; Monteiro I; Castro S; Espejo-Arce X; Bahamondes L
    Hum Reprod; 2010 May; 25(5):1158-64. PubMed ID: 20185512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.